Edgar Filing: BioScrip, Inc.

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Coliseum Capital Management, LLC

2. Date of Event Requiring Statement (Month/Day/Year)
03/09/2015

3. Issuer Name and Ticker or Trading Symbol
BioScrip, Inc. [BIOS]

(Last)

(First)

(Middle)

METRO CENTER,Â 1 STATION PLACE, 7TH FLOOR SOUTH

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

STAMFORD,Â CTÂ 06902

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security
(Instr. 4)

2. Amount of Securities Beneficially Owned
(Instr. 4)

3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)

4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Coliseum Capital Management, LLC METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD,Â CTÂ 06902	Â X	Â	Â	Â
Shackelton Christopher S METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD,Â CTÂ 06902	Â X	Â	Â	Â
Coliseum Capital, LLC METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD,Â CTÂ 06902	Â X	Â	Â	Â
COLISEUM CAPITAL PARTNERS L P METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD,Â CTÂ 06902	Â X	Â	Â	Â
Coliseum Capital Partners II, L.P. METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD,Â CTÂ 06902	Â X	Â	Â	Â
Gray Adam METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD,Â CTÂ 06902	Â X	Â	Â	Â

Signatures

Coliseum Capital Management, LLC, By: /s/ Christopher Shackelton, Manager		03/11/2015
^**Signature of Reporting Person		Date
/s/ Christopher Shackelton		03/11/2015
^**Signature of Reporting Person		Date
Coliseum Capital, LLC, By: /s/ Christopher Shackelton, Manager		03/11/2015
^**Signature of Reporting Person		Date
Coliseum Capital Partners, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Christopher Shackelton, Manager		03/11/2015
^**Signature of Reporting Person		Date
Coliseum Capital Partners II, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Christopher Shackelton, Manager		03/11/2015
^**Signature of Reporting Person		Date
/s/ Adam Gray		03/11/2015
^**Signature of Reporting Person		Date

Explanation of Responses:

No securities are beneficially owned
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Â Remarks: ChristopherÂ ShackeltonÂ isÂ aÂ directorÂ ofÂ theÂ Issuer.Â AsÂ aÂ result,Â theÂ followingÂ personsÂ mayÂ beÂ deemedÂ directorsÂ byÂ deputizationÂ ofÂ theÂ IssuerÂ solelyÂ forÂ purposesÂ ofÂ SectionÂ 16Â ofÂ theÂ SecuritiesÂ ExchangeÂ ActÂ ofÂ 1934,Â asÂ amended:Â ColiseumÂ CapitalÂ Management,Â LLC;Â ColiseumÂ Capital,Â LLC;Â ColiseumÂ CapitalÂ Partners,Â L.P.;Â ColiseumÂ CapitalÂ PartnersÂ II,Â L.P.;Â andÂ AdamÂ Gray.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.